(Q36070612)

12 August 2017

1 reference

title

Migraine and antiphospholipid antibodies. (English)

1 reference

12 August 2017

G E Tietjen

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 April 1992

1 reference

12 August 2017

1 reference

12 August 2017

volume

12

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

69-74

1 reference

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

The demonstration of lupus anticoagulant by an enzyme-linked immunoadsorbent assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Amaurosis fugax associated with antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Migraine and anti-phospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Cerebrovascular ischemia associated with lupus anticoagulant

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Migraine and the lupus anticoagulant. Case reports and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Migrainous phenomena in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Flunarizine vs. pizotifen in migraine prophylaxis: a review of comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

A study of migraine in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Cerebral infarction associated with lupus anticoagulants--preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Amaurosis fugax under the age of 40 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Amaurosis fugax. A unselected material

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Late-life migraine accompaniments--further experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Migraine thrombocytopenia, and serotonin metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Anticardiolipin antibodies in autoimmune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Antiphospholipid antibodies, prethrombotic states, and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Lupus anticoagulant and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Platelet serotonin (5-HT) and 5-HT releasing factor in plasma of migrainous patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

Migraine: a platelet disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

The platelet and migraine: a nonspecific association

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1992.1202069.X

10.1046/J.1468-2982.1992.1202069.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference